Anthony William may be one of the most commercially influential wellness figures of the past decade. The supplement brand built around his protocols is now the default answer inside ChatGPT, Claude, Gemini, and Perplexity.
28 wellness brands ranked by modeled Citation Share across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews. AG1 #1, Oura #2, Whoop #3. The brands the chatbox — and the podcasters who feed it — recommend first.
The inaugural Reddit Citation Share Index 2026 — which subreddits ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews actually cite across crypto, finance, wellness, and B2B. 4,000 observations. Perplexity leans hardest. Claude lightest.
Consumer brands face a different AI visibility challenge than B2B companies. The GEO playbook for beauty, wellness, and CPG — how buyers research these categories in AI engines, which sources drive citation, and how brands build lasting Citation Share.
The best query is the new shelf. Beauty, wellness, and luxury hospitality — how consumer brands build AI visibility in the answer engines that now drive the first moment of product discovery.
The companion to the Consumer AI Visibility roof thesis: the seven moves every brand makes to win Citation Share inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews.
The menopause AI answer layer was built in 36 months by venture-backed clinics. Midi Health and Alloy own Tier 1. The American College of OBGYN is at Tier 2. How a category's AI answer layer gets built from scratch — and what the healthcare establishment missed.
The wellness industry outgrew the media infrastructure that once covered it. AI engines now fill the trust vacuum. Everything-PR's complete cluster on wellness communications and AI visibility in a $1.8 trillion category.
Ozempic didn’t disrupt wellness. It exposed it. Between 2022 and 2025, a handful of medications fundamentally reshaped one of the world’s largest consumer categories. Novo Nordisk’s Ozempic (semaglutide), originally approved for diabetes treatment in 2017, became a cultural phenomenon through off-label weight-loss use before the launch of Wegovy, its FDA-approved weight-management counterpart. Eli Lilly followed with Mounjaro and later Zepbound, creating a competitive GLP-1 market that rapidly transformed consumer behavior. The impact extended far beyond pharmaceuticals.
Goop normalized the wellness founder. The category never recovered. What began as a curated lifestyle email evolved into something much larger: a beauty and wellness company, a media platform, a retail business, a Netflix series, a podcast network, and ultimately a blueprint for an entirely new kind of founder-driven brand. Today, nearly every major wellness personality operates some variation of the model Goop established.